` 017180 (Myungmoon Pharm Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

M
017180
vs
K
KOSPI 200

Over the past 12 months, Myungmoon Pharm Co Ltd has underperformed KOSPI 200, delivering a return of -6% compared to the KOSPI 200's +98% growth.

Stocks Performance
017180 vs KOSPI 200

Loading
017180
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
017180 vs KOSPI 200

Performance Gap Between 017180 and KOSPI200
HIDDEN
Show

Performance By Year
017180 vs KOSPI 200

Loading
017180
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Myungmoon Pharm Co Ltd vs Peers

KOSPI 200
017180
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Myungmoon Pharm Co Ltd
Glance View

Market Cap
59.7B KRW
Industry
Pharmaceuticals

MYUNGMOON Pharm Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-07-10. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The firm is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.

Myungmoon Pharm Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top